Cargando…
Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is a recognized clinical entity in patients receiving unfractionated heparin and low–molecular weight heparin. Currently, diagnosing HIT includes the combination of a physician’s clinical suspicion based on a clinical scoring system and a series of laboratory t...
Autores principales: | Sahu, Kamal K, Jindal, Vishal, Anderson, Joseph, Siddiqui, Ahmad D, Jaiyesimi, Ishmael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443028/ https://www.ncbi.nlm.nih.gov/pubmed/32884385 http://dx.doi.org/10.2147/JBM.S232648 |
Ejemplares similares
-
The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia
por: Jindal, Vishal, et al.
Publicado: (2018) -
Cancer treatment during COVID-19 pandemic
por: Jindal, Vishal, et al.
Publicado: (2020) -
Usefulness of anti-PF4/heparin antibody test for intensive care unit patients with thrombocytopenia
por: Park, Sang Hyuk, et al.
Publicado: (2012) -
Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature
por: Ezekwudo, Daniel E., et al.
Publicado: (2017) -
Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
por: Kelly, Julie, et al.
Publicado: (2021)